MiNK Therapeutics, Inc (INKT) - Market Cap to Net Income Ratio

Corporate emblem and logo of MiNK (INKT)

International challenges with testing and patents are hindering the development of MiNK Therapeutics, Inc. (INKT), yet its high standing within the scientific community ensures support from specialized funds. The market price trend on the GURU.Markets platform serves as an indicator of these processes, reaching -4.40. The business relies on creating mass production methods for iNKT cells to combat dense neoplasms, establishing a new standard for affordable therapy.

INKT minktherapeutics.com: Price to Earnings Ratio in the range 07/04/2022 - 11/18/2026

Analytical breakdowns for MiNK Therapeutics, Inc.

- market price and analyst price targets:
Comprehensive company analysis:INKT MiNK
Manufactured product of MiNK Therapeutics, Inc.

The P/E ratio reflects the relationship between the market value of MiNK Therapeutics, Inc. (INKT) and its net income, measuring the premium investors are paying for every dollar of current earnings. Since cell therapy developments are in early stages with negative cash flow, the current P/E valuation reflects speculative market expectations regarding future innovations rather than actual profitability.

Competing companies

Market Cap to Earnings ImmunityBio IBRX|P/E Multiple IMCR|Janux Therapeutics (JANX) - Market Cap to Net Income Ratio|Arcus Biosciences Inc - Price to Earnings Ratio|Zymeworks (ZYME) - Market Cap to Earnings|TNGX: Price to Earnings Ratio|Company Value to Net Income IOVA (Iovance Biotherapeutics, Inc.)|IMTX: P/E Multiple|XNCR - Business Payback Period|Price to Earnings Ratio compasstherapeutics.com|Price to Earnings Ratio replimune.com (REPL)|Price to Earnings Ratio Lyell (LYEL)|Price to Earnings Ratio Innate Pharma, S.A. IPHA|Pyxis Oncology Inc. - Price to Earnings Ratio|P/E Multiple Compugen Ltd. CGEN|IOBT - Price to Earnings Ratio|STRO (sutrobio.com) - Price to Earnings Multiple|werewolftx.com (HOWL) - Price to Earnings Ratio|Market Cap to Earnings Immix Biopharma, Inc. (IMMX)|Price to Earnings Ratio ALXO|CUE (Cue Biopharma, Inc.) - Market Price to Net Income Ratio|Price to Earnings Ratio PDSB (PDS Biotechnology)|Market Price to Net Income Ratio SONN|P/E Multiple MAIA (MAIA Biotechnology, Inc.)|Company Value to Net Income LIMN|Lava Tx - P/E Multiple|Market Cap to Earnings NextCure Corporation|Leap Tx (LPTX) - Price to Earnings Ratio|Intensity Therapeutics Inc - Company Value to Net Income|SNSE (Sensei Bio) - P/E Multiple|P/E Multiple Theriva Biologics Inc|Price to Earnings Ratio gritstonebio.com (GRTS)|P/E Multiple Kineta Bio (KA)|NexImmune Inc - Price to Earnings Ratio|turnstonebio.com (TSBX) - Market Cap to Earnings|VCNX: Price to Earnings Ratio|Company Value to Net Income HARP (Harpoon Therapeutics, Inc.)